Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment.
Fiche du document
18 mai 2020
- doi: 10.15698/cst2020.07.224
- issn: 2523-0204
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.15698/cst2020.07.224
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32656498
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2523-0204
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_1DAAFE3927F76
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Medical pharmacology Drug effects Products, Natural Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
A. Gomez-Cadena et al., « Immune system activation by natural products and complex fractions: a network pharmacology approach in cancer treatment. », Serveur académique Lausannois, ID : 10.15698/cst2020.07.224
Métriques
Partage / Export
Résumé
Natural products and traditional herbal medicine are an important source of alternative bioactive compounds but very few plant-based preparations have been scientifically evaluated and validated for their potential as medical treatments. However, a promising field in the current therapies based on plant-derived compounds is the study of their immunomodulation properties and their capacity to activate the immune system to fight against multifactorial diseases like cancer. In this review we discuss how network pharmacology could help to characterize and validate natural single molecules or more complex preparations as promising cancer therapies based on their multitarget capacities.